CD13

GWB-1CEECA

290

WM15

Spleen cells from immunised BALB/c mice were fused with cells of the mouse NS1 myeloma cell line.

Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant

Flow Cytometry - Neat 1. Bradstock. K. F. et al. (1985) Human myeloid differentiation antigens identified by monoclonal antibodies: Expression on leukaemic cells. 2. Bradstock. K. F. et al. (1985) Myeloid progenitor surface antigen identified by monoclonal antibody. 3. Favaloro. E. J. et al. (1988) Further characterisation of myeloid antigens (\' gp160. 95\' . \' gp150\' and \' gp567\' ): Investigation of epitope heterogeneity and non-haemopoietic distribution using panels of monoclonal antibodies belonging to CD11b. CD13 and CD33. 4. Favaloro. E. J. (1991) CD13 (\' gp150\' . Aminopeptidase-N): Co-expression on human endothelial and haemopoietic cells. with conservation of functional activity. 5. Favaloro. E. J. et al. (1993) The hepatobiliary disease marker serum alanine-aminopeptidase predominantly comprises an isoform of the haematological myeloid differentiation antigen and leukaemia marker CD13/gp150. 6. Favaloro. E. J. et al. (1993) CD13 (gp150; aminopeptidase-N): Predominant functional activity in blood is localised to plasma and is not cell surface associated.